In line with these observations, differential accessibility analysis between AML and T-ALL established that accessible C/EBP and SPI1 sites are a hallmark of AML, whereas T-lymphoid leukemias are driven by LEF1, TCF7, and RUNX1, among others. The gene discussed is LEF1; the disease is acute myeloid leukemia.